A year into the pandemic, infection rates are falling. Hospitals are quieter; morgues are emptier. Emboldened by vaccines, we’re dropping our masks and stepping closer. Slowly […]
Eli Lilly & Co. presented highly anticipated details from a mid-stage study showing that its experimental drug modestly slowed Alzheimer’s disease progression over about 18 months.
Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In […]
Increases in the use of telehealth during the coronavirus pandemic among people with private insurance has occurred mostly among those who are more affluent and those […]